advertisement
Abstract #109448 Published in IGR 24-1
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Grainger RM; Lauderdale JD; Collins JL; Trout KL; McCullen Krantz S; Wolfe SS; Netland PAOcular Surface 2023; 29: 423-431
The inaugural Aniridia North America (ANA) Symposium was held on the first weekend in November 2021 in Charlottesville, VA, at the University of Virginia. The purpose of this meeting was to bring together an international group of scientists, physicians, patient advocacy groups, and individuals with aniridia to discuss recent advances in knowledge about aniridia and other congenital eye diseases and the development of potential treatments for congenital eye disorders using personalized medicine. Leaders in several areas of eye research and clinical treatment provided a broad perspective on new research advances that impact an understanding of the causes of the damage to the eye associated with aniridia and the development of novel treatments for this and related disorders. Here we summarize the research discussed at the symposium.
Aniridia North America, LaGrange, IL, 60525, USA; Department of Biology, 326 Gilmer Hall University of Virginia 485 McCormick Road P.O. Box 400328 Charlottesville, VA 22904, USA. Electronic address: rmg9p@virginia.edu.
Full article